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General comments 
This paper attempts to understand optimal ventilation rates at the national level across 26 European 
countries and to contrast the benefits of optimizing ventilation with filtration of outdoor air 
pollution and control of indoor sources. This is an important topic given the key role of the housing 
sector in tackling both air pollution and climate change. Although the methods used are relatively 
simplistic, they are appropriate for analyses performed at the scale presented in the paper. The 
findings and conclusions are well supported by the results. I would therefore support publication. 
However, I believe the manuscript would benefit from a stronger statement of the aims of the work 
and some clarifications regarding the methods (see below).  
My main concern relates to the assumption made by the authors that indoor-generated PM2.5 is 
equally as harmful to health as outdoor-generated PM2.5. There is little evidence to support this 
(though it is quite a commonly made assumption). I would like to see some form of sensitivity 
analysis in relation to this assumption, since it may have an impact on the final results (though 
probably not on the ultimate conclusions). 
More detailed comments can be found below. I consider the suggested revisions to be relatively 
minor. 
Specific comments 
1. Is the question posed original, important and well defined?
The research question posed by the paper is important and I believe the methods used are 
appropriate to answer it. However, the aims of the paper are not currently well stated (in both the 
main text and in the abstract). The main statement of the aims comes towards the end of page 5, 
which states “This work aims to summarize the current understanding of the sources of health risks 
in indoor environments and their relationship to ventilation requirements”. This doesn’t really 
capture what the authors have actually done. There is a slightly better statement of the aims hidden 
in the Methods (top of page 7) but even this doesn’t quite feel sufficient. 
2. Are the data sound and well controlled?
Yes, although the source of some of the input data can be made clearer in the text, especially in 
relation to Table 2 (see below). 
3. Is the interpretation (discussion and conclusion) well balanced and supported by the data?
Yes. 
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4. Are the methods appropriate and well described, and are sufficient details provided to allow
others to evaluate and/or replicate the work?
The methods are generally well described. However, I have a few specific issues (see the additional 
comments below). 
5. What are the strengths and weaknesses of the methods?
The methods are based on relatively simplistic tools (both the mass-balance exposure model and the 
risk/health impact model). However, I think they are appropriate for the type of analysis presented 
in the paper. 
My main concern relates to the assumption of equal health risk associated with both outdoor- and 
indoor-generated PM2.5. The authors discuss this briefly in the Discussion section but this 
assumption is highly uncertain since almost all of the published epidemiology is based on outdoor 
PM2.5. The paper would benefit from greater emphasis on the sensitivity of the results to this 
assumption. Perhaps, the analysis (or part of it) could be repeated without the effects of indoor-
generated PM2.5 or with a reduced exposure-response coefficient? 
6. Can the writing, organization, tables and figures be improved?
Although the manuscript is generally well written, there are reoccurring problems, most importantly 
missing articles throughout the paper (e.g. a, the). For instance, in the abstract, “Based on 
measurements of the European Environment Agency (EEA),…” and “A framework for developing 
European health-based ventilation guidelines…” would be preferable. I realise that English is not the 
authors’ first language (and, again, I should stress that most of the language used is very good). 
However, I think the paper would benefit from a thorough edit by a native English speaker. 
Also, the figures appear to be quite pixelated and may not be in an appropriate format for 
publication. 
7. When revisions are requested.
No preference. 
8. Are there any ethical or competing interests issues you would like to raise?
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9. Additional comments
• I believe the abstract would benefit from a little editing. At present, the Background section feels
unnecessarily long and there isn’t enough detail in either the Methods or Results sections. The
methods used for the health impact calculations aren’t mentioned at all, despite being key to the
paper. At the moment, I don’t feel the main results are clearly stated in the abstract.
• The paper refers throughout to “optimization”. I think a mathematician might object to the use of
the term because the method doesn’t actually use a formal optimization process. I don’t think
this is too much of a problem but I do think a clear statement of what the authors mean by
optimization would be helpful (e.g. in the Methods). As I understand it, the “optimal” ventilation
rate is just taken to be the one for which the health burden is smallest.
• I found some parts of the description of the risk model confusing, in particular towards the
bottom of page 7. Firstly, the text states that the models are based on a predefined population
attributable burden of disease for each exposure and disease. Is this simply referring to the
calculation described later in the section (bottom of page 8)? Secondly, the text then states that
“national estimates are then calculated from the national burden of disease data by scaling the
attributable fraction according to the ratio of national versus European indoor concentration
estimates for each pollutant”. I’m afraid I could not follow the point being made here. Which
“European” estimates are being referred to?
• On page 8 it is stated that “Traditional risk assessment methods estimate these [mortality and
morbidity] separately as numbers of cases”. I don’t really agree with this statement. There are
many health impact assessment methods which can consider both together and which are not
incidence-based.
• The source of the data presented in Table 2 was not clear to me. Do these values relate to
previous work by the authors? The source(s) used should be explained and appropriate
references provided.
• The section describing the basis for the assumed source control levels (page 11) can be improved.
Although the authors provide an explanation of the methods that can be used to achieve such
source control for each pollutant, it is not clear how the specific reduction % was decided upon in
each case. Are the reductions based on evidence or just plausible best guesses? For example,
how do you know that implementing compulsory alarms will reduce CO sources by exactly 90%?
The section would benefit from additional references to supporting literature.
• I do not understand why the source control scenario (scenario 3) did not also include an element
of ventilation optimization. The start of the section describing the scenarios suggests that
ventilation optimization would be “complemented” first by filtration and then by source control
(page 9). This suggests that a ventilation optimization component would appear in all scenarios.
Choosing just one “optimal” ventilation rate makes it difficult to ascertain the relative benefits
due to ventilation and source control.
• There is a line on page 14 which states “substantial reductions have been proposed in the earlier
work within the EU funded IAIAQ project”. It is not clear what reductions are being referred to
here. Is it reductions in the burden of disease due to indoor exposures? Why have reductions
been proposed?
• The term “EU-26” is used throughout the paper and should be defined somewhere.
• There are two occasions where references are missing in the text (bottom of page 8 and below
Table 3).
Dear Sotiris 
Please find my detailed comments on the attachment and my review below: 
The manuscript "Healthy-Polis 1476-069X-14-S1-S6" focusses on the calculation of the annual 
burden of disease caused by exposure to indoor air pollution. 
This is very important work, given that the indoor environment is greatly ignored in relation to 
health. 
The MS is generally well written and certainly merits publication. 
Apart from some minor editing, as indicated in the attachment, my comments mainly aim to 
improve the reader's understanding. The areas requiring clarification are highlighted in the 
attachment together with some comments. The two most important ones are as follows: 
1. Methods: My understanding is that the exposure analysis refers only to indoor exposure in the
residential environment, without considering any time spent outdoors or in other indoor 
microenvironments; however, this is not clear in the text.  Can you please clarify what the building 
stock represents. 
2. The section on the "Risk model" directs the reader to several  references of previous work.
However, the reader may not be familiar with these methodologies and, most importantly, this 
significant part of the paper should stand alone. To enable a more friendly reading, the authors are 
kindly required to provide the data used in the methodology, step by step, as supplementary data 
(i.e. BoD, national estimates/statistics, PAF etc).This would improve a lot the quality and value of this 
publication. 
Many thanks 
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Abstract  
Background 
The annual burden of disease caused by inadequate indoor air quality is estimated to 
correspond to a loss of over 2 million healthy life years in the European Union (EU). 
This burden is caused by sources of indoor air pollution, including polluted outdoor 
air used to ventilate indoor spaces. Based on measurements of European Environment 
Agency (EEA), approximately 90% of EU citizens live in areas where the World 
Health Organization (WHO) guidelines for air quality for particulate matter sized < 
2.5 mm (PM2.5) are not met. Because sources of pollution reside in both indoor and 
outdoor air, selecting the most appropriate ventilation strategy to ensure that the 
health risks associated to exposure inside buildings are reduced is not simple and 
straightforward task.  
Methods 
Framework for developing European health-based ventilation guidelines was created 
in 2010-2013 in the EU-funded HEALTHVENT project. As a part of the project 
potential of efficient control policies to reduce the burden of disease caused by indoor 
exposures was estimated. Analysis was based on scenario comparison using a model, 
which was based on mass-balance framework and changes in ventilation level. 
Results 
The quantitative comparison of three main policy approaches, (i) changing  
ventilation rates only; (ii) filtration of outdoor air; and (iii) indoor source control, 
showed that all three approaches are able to provide substantial reductions in the 
health risks varying from approximately 20% to 44%, corresponding to 400 000 and 
900 000 saved healthy life years in EU-26. 
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Conclusions 
Health effects of indoor air exposures can be decreased by increasing ventilation and 
the present modelling shows that controlling indoor air sources plays a major role 
when selecting appropriate ventilation rate. In a case where indoor sources cannot be 
removed or their emissions cannot be limited to an accepted level, ventilation needs to 
be increased to remove remaining pollutants. In these cases outdoor air pollution 
become the major source of pollution in indoors, and it needs to be taken into account. 
Particulate matter, mainly coming from outdoors to indoors, is the main cause of 
health effects of indoor exposures in all European countries. 
Background  
In the period 2006-2010, focus on indoor air quality has been raised by WHO, who 
has issued specific guidelines addressing air exposure in indoor spaces [1, 2]. Already 
during the previous two decades WHO had coordinated systematic reviews of 
scientific evidence and set Air Quality Guidelines [3, 4] although not specific for 
indoor air.  
Requirements for indoor air quality (IAQ) in buildings is prescribed by existing 
standards for ventilation, but are often poorly related on health. At present  many 
ventilation standards (e.g. EN15251 [5]) define ventilation requirements in non-
industrial buildings to meet comfort requirements of occupants, specified by the 
percentage of dissatisfied persons with indoor air quality and/or by the intensity of 
odour. While comfort is an important outcome, it does not fully reflect more serious 
health impacts like asthma, allergies, chronic obstructive pulmonary disease, 
cardiovascular diseases, lung cancer and acute toxication that are caused by exposures 
to pollutants present in indoor air. There are no European guidelines which 
recommend how the buildings should be ventilated to reduce the health risks of the 
occupants’ exposed to indoor air pollutants. 
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Direct scientific evidence on the relationship between ventilation and health is quite 
limited. Wargocki et al. (2002) [6] reviewed 105 papers published in peer-reviewed 
scientific journals, out of which 30 papers were judged to provide sufficient 
information on ventilation, health effects, data processing, and reporting. Ventilation 
was considered to be strongly associated with comfort (perceived air quality, PAQ) 
and health (including sick building syndrome (SBS) symptoms, inflammation, 
infections, asthma, allergy, and short-term sick leaves), and an association between 
ventilation and productivity (performance of office work) was indicated.  
Similar results were obtained in the review by Seppänen et al. (2004) [7]. They 
concluded that the existing literature indicates that ventilation has a significant impact 
on several important human outcomes including: (1) communicable respiratory 
illnesses (disease prevalence or sick days); (2) sick building syndrome (SBS) 
symptoms; (3) task performance and productivity, and (4) perceived air quality (PAQ) 
as judged by building occupants or recruited sensory panels of assessors; and (5) 
respiratory allergies and asthma.  
Li et al. (2007) [8] performed a systematic review of the role of the built environment 
in the transmission of airborne infectious agents. Specifically, they examined whether 
there was sufficiently strong evidence in the current literature to substantiate a 
contributory role of ventilation rates and airflow patterns in the airborne transmission 
of infectious agents in different indoor settings. They concluded that there is strong 
evidence substantiating the association between ventilation, air movements in 
buildings and the transmission/spread of infectious diseases such as measles, 
tuberculosis, chickenpox, influenza, smallpox and severe acute respiratory syndrome 
(SARS).  
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Sundell et al. (2011) [9] identified 27 papers published in peer reviewed journals 
providing sufficient information on both ventilation rates and health effects. Multiple 
health endpoints showed similar relationships with ventilation rate and were 
biologically plausible, although the literature did not provide clear evidence on 
particular agents. Higher ventilation rates in offices, up to about 25 l/s per person, 
were shown in the reviewed literature to be associated with reduced prevalence of 
SBS symptoms. Limited data suggested that inflammation, respiratory infections, 
asthma symptoms and short-term sick leave increase with lower ventilation rates. 
Home ventilation rates above 0.5 air changes per hour (h
-1
) were shown in the 
reviewed papers to be associated with reduced risk of allergic manifestations among 
children in a Nordic climate. 
None of the studies included in the reviews specifically addressed the role of outdoor 
air quality on indoor exposures, even though 90% of EU citizens live in areas where 
the WHO guidelines for air quality for PM2.5 is not met [10]. Neither was the 
existence of indoor air sources systematically analysed nor exposure levels quantified 
or considered when associating ventilation and health. Therefore the support from 
these previous studies on determining the best combination of source control and 
ventilation levels is limited. This work aims to summarize the current understanding 
of the sources of health risks in indoor environments and their relationship to 
ventilation requirements. The methods presented here allow for informed health-based 
optimization of efforts aimed at reducing harmful exposures and improving health of 
the occupants. The results are intended for development of national and international 
guidelines and standards, and can also be used as background information when 
analysing indoor air quality related issues in buildings.  
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Methods 
Exposures 
Ventilation plays a dual role in formation of indoor pollutant concentrations: on one 
hand it removes pollutants generated indoors from indoor spaces by ventilating the 
space with outdoor air, on the other hand, ventilation introduces outdoor air pollutants 
indoors [11, 12]. Assuming a constant outdoor pollution level and constant 
penetration efficiency, increasing ventilation directly leads to increased indoor 
exposures to outdoor pollutants. Even in the case of efficient filtering of particles in 
the intake air, detailed studies have shown that a substantial fraction of the outdoor air 
enters indoors via windows, doors, ventilation ducts, and cracks and leaks in the 
building envelope, leading to much lower actual filtration efficiency  [13]. 
Due to the counter-acting roles of indoor and outdoor air sources on indoor exposures, 
a mass-balance model is needed to address it when defining prevailing indoor 
concentrations. A commonly used approach based on Dockery and Spengler [14] and 
adopted in Hänninen et al.  [11], [15] is as follows: 
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where Ci is the total indoor concentration (µg m
-3
) of the pollutant in question, Ca is 
the concentration in the intake air, P is the probability of the pollutant remaining 
suspended after penetrating through the building envelope, α is air exchange rate (h-1), 
k is the deposition rate of the pollutant indoors (h
-1
), G is the indoor generation level 
(µg h
-1
), V is the volume and t is the temperature of the indoor space. The third term 
covering the transient impacts of changing concentration can be considered zero for 
the sake of long-term average exposures. Detailed input data and more details of 
calculations are presented in Hänninen and Asikainen (2013) [16]. 
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Because the aim of this study is to estimate how changes in ventilation affect 
exposures, the probability distributions of national ventilation rates in a building stock 
of year 2010 had to be estimated. Surprisingly limited data of measured ventilation 
rates are available for European countries. Due to this, available measured data was 
reviewed and a regression model was created combining the climatological and 
economical differences in the building stocks with ventilation rates. Further modelling 
with a Bayesian subjective probability approach was used for generation of lognormal 
probability distributions for ventilation rates in each EU-26 country  (Table 1, method 
described in detailed elsewhere [17]). 
 
Table 1. 
Risk model 
Large number of indoor air pollutants has been associated with health responses, but 
some of those either play a small role from the point of view of public health, or pose 
challenges for the exposure assessment or quantification of the burden of disease. 
Health determinants of housing in general are discussed in WHO 2011 [18], safe 
levels of specific chemicals indoors in WHO 2010 [2] and guidelines for exposure to 
dampness and mould specifically in WHO 2009 [1]. The current enhancement of the 
health impact assessment with the above described mass-balance approach to account 
for variable ventilation is built on the previous achievements of EnVIE [19] and 
IAIAQ projects [20] and the corresponding models for environmental burden of 
disease caused by indoor air quality. These models were based on a predefined 
population attributable burden of disease (BoD) for each exposure and disease and 
national estimates are then calculated from the national burden of disease data by 
scaling the attributable fraction according to the ratio of national versus European 
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indoor concentration estimates of each pollutant. (i.e. PM2.5, outdoor bioaerosols, 
VOC, carbon oxide (CO) radon and dampness). In the current work the earlier PM2.5, 
radon and dampness models were updated to the relative risk-based population 
attributable fraction (PAF) approach but keeping the IAIAQ disease classification. In 
addition, second hand smoke exposures at home were added using exposure data from 
a European survey [21].  
Exposures to environmental pollutants are associated with increased mortality and 
morbidity. Traditional risk assessment methods estimate these separately as numbers 
of cases. The results from such incidence-based models are not comparable over 
different types of health endpoints and to improve comparability of impacts on 
various types of diseases and including mortality, disability adjusted life years 
(DALY) has been proposed as a common metric [22]. 
The burden of disease methodology makes the years of life lost (YLL) due to 
premature mortality and years lived with a disability (YLD) comparable and is 
summing them up as disability adjusted life years (DALY)  
Eq 2  YLDYLLDALY   
The disabilities caused by various types of diseases are calculated accounting for the 
duration of the disease (L) and scaled using a disease specific disability weight (DW): 
Eq 3  LDWYLD   
In the current work the fraction of disease caused by the indoor exposures to various 
pollutants is estimated using national statistics on the overall background burden of 
the target diseases (Table 1) and calculating the population attributable fraction (PAF) 
as [Error! Reference source not found.]:  
Eq 4  1)1(
)1(
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where f is the fraction of population exposed to a given factor and RR is the relative 
risk of the exposed population. Now if the background burden of disease (BoD) is 
known the environmental burden of disease (EBD) caused by the current exposures 
(Table 2) can be calculated as 
Eq 5  BoDPAFEBD   
The relative risk at the current exposure level can be estimated from epidemiological 
relative risk (RR°) expressed per a standard exposure increment, e.g. 10 µg m
-3
:  
Eq 6  
  ERRE RReRR  ln  
WHO estimates for national burden of disease in 2004 were used for the background 
BoD [24]. Pollutant specific diseases and methodology are presented in Table 3. 
 
Table 2. 
Table 3. 
Exposure control scenarios 
Three alternative exposure control scenarios were evaluated using the mass-balance 
enhanced burden of disease model to evaluate their efficiency to reduce BoD. The 
exposure control scenarios start from optimizing the ventilation rates only. As it 
proves inefficient, it is complemented firstly with control of filtration of outdoor 
pollutants and secondly with control of indoor sources. 
Dilution by optimal ventilation 
The first exposure reduction scenario is defined as finding the health-based optimum 
ventilation rate without any other actions that change indoor or outdoor sources. In 
this scenario the pollutant concentrations from indoor and outdoor sources compete so 
that pollutants from indoor sources are decreasing and pollutants from the outdoor 
sources are increasing when the ventilation rate is increased. The health-based 
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optimum level of ventilation is solved for each country among EU-26 by calculating 
burden of disease with ventilation rates from 0.1 to 50 lps pp. 
The calculations assume that all indoor originating exposures follow the mass-balance 
dilution even though this is not self-evident for several indoor originating pollutants, 
especially radon, dampness, mould and carbon monoxide. Radon infiltrates typically 
from the soil below the buildings, and the infiltration may react to the under pressure 
indoors, which may increase in some ventilation systems at higher ventilation rates. 
Dampness may also be created by condensation and may thus increase at higher 
ventilation rates. Carbon monoxide is lethal at high exposure levels and more efficient 
dilution by higher ventilation may not be sufficient. However, for all these pollutants 
the benefits of higher ventilation rates are calculated assuming the mass-balance for a 
constant source term. 
Filtration of intake air 
Previous analyses of the sources of indoor exposures have shown that outdoor air is a 
significant source of exposures. Therefore the second scenario was determined as an 
attempt to control the burden of disease by filtration the exposures originating from 
outdoor air. Because both ultrafine and coarse particles and chemically reactive 
pollutants like ozone have lower infiltration factors than PM2.5, dominated by 
accumulation mode particles, the filtration was specified for PM2.5 particles. 
Three levels of filtration were compared. The baseline estimates assume that 90% of 
the outdoor PM2.5 mass concentration penetrates indoors. In addition, realistic but 
increasingly challenging penetration levels of 70% and 50% were evaluated. These 
correspond to effective filtration of PM2.5 mass concentration by 27% and 45%, 
respectively, filtration levels that can be achieved in real buildings at least when using 
mechanical ventilation systems [13]. When discussing the filtration efficiencies of 
filters and the above mentioned penetration efficiencies, it has to be noted that the 
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penetration efficiency is defined for the building, accounting for leaks and ventilation 
from windows, doors etc. 
The health-based optimum ventilation was defined in this scenario also, and used 
when calculating the burden of disease results and the reduction potential compared to 
the baseline scenario.  
Source control and minimum ventilation (4 lps pp) 
The third approach to optimizing ventilation for health focuses first on indoor sources 
of exposures. Now, instead of attempting to dilute these sources as they are, they are 
first assumed to be controlled by other means as much as technically feasible before 
optimizing the ventilation for health. The assumed control potentials for the 
considered pollutants were: 
• -90% for radon, carbon monoxide (CO) and second hand smoke (SHS) 
• -50% for volatile organic compounds (VOC) and dampness 
• -25% for particulate matter (PM2.5) 
These hypothetical source controls were defined to approach maximum technically 
feasible reductions. The radon estimate assumes efficient application and control of 
radon safe construction in radon-prone areas combined with control of second hand 
smoke exposures known to act synergistically with radon. Efficient second hand 
smoke reductions have already been demonstrated in Finland in both workplaces and 
in homes resulting a decrease in proportion of adolescents exposed to SHS from 17% 
in 1991 to 6% in 2009 [25] and the SHS policies are moving forward also on at 
European level. The carbon monoxide controls were aimed to be implemented by 
compulsory alarms that will allow for identification of malfunctioning devices before 
the risks occur. 
VOC controls can be reached by comprehensive labelling systems for low emission 
products. Dampness controls need to combine structural improvements with 
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active/online and passive warning sensors. The most challenging element was 
considered to be particulate matter. The proposed 25% reduction can be achieved with 
target exhausts in kitchens, avoiding use of candles and improved design of 
combustion devices. 
To provide some sensitivity analysis to estimate the effectiveness of source control, 
two other scenarios with lower and higher source control capabilities were also 
analysed. In the lower source control scenario (scenario 3.1) it was assumed a 
reduction of 80% for radon, CO and SHS and 25% reduction of PM2.5, VOC and 
dampness exposures. In the higher source control scenario (scenario 3.2) a total 
control (100%) of radon, CO and SHS and 75% reduction of PM2.5, VOC and 
dampness exposures were assumed. 
In all source control scenarios the ventilation level was set to be 4 lps pp, which was 
defined as base ventilation rate in cases when ventilation must handle only human 
bio-effluent emissions (carbon dioxide (CO2) and moisture) by work done in 
HealthVent to define the health based ventilation requirements [26].  
Results  
Attributable burden of disease in 2010 
Exposures to indoor and outdoor originating pollutants were associated with a burden 
of disease corresponding to an annual loss of 2.1 million DALYs in EU-26. More than 
half of this burden (1.28 million DALYs) is caused by exposures to outdoor air 
pollution indoors. The remaining 0.74 million DALYs are associated with pollutants 
from various indoor sources. 
The burden of disease caused by indoor exposures is dominated by cardiovascular 
(CV) diseases; 45% of the total burden comes from CV-diseases associated with 
outdoor particles, with an additional 12 % caused by indoor sources of exposures of 
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particles and second hand smoke (Figure 1). Cardiovascular diseases are followed by 
asthma (total of 12%) and lung cancer (23%). The remaining 8% is divided between 
various respiratory symptoms and conditions. 
 
Figure 1. 
The total burden of disease for individual countries varies between 2000 and 10 000 
DALYs per million (Figure 2). The highest burden in Bulgaria is almost five times 
higher than that in Sweden. The higher levels in East-European countries are 
dominated by high contributions from outdoor sources. The contribution of outdoor 
sources varies between 46% (Ireland) to 75% (Bulgaria). The EU-26 average burden 
corresponds to slightly over 4000 DALY in a year per one million population.  
 
Figure 2. 
Source contributions to burden of disease 
Overall in EU-26, over 50% of the total annual burden of disease associated with 
indoor exposures (4000 DALYs/million) is estimated to be caused by PM2.5 
originating from outdoor air, followed by particles from indoor sources, and radon 
(Figure 3).  
The contribution of different sources to the total DALYs varies between countries. 
This can be seen when comparing the sources of the burden of disease in Finland 
(Figure 3) and in other EU-26 countries (Table 4) with the population-weighted mean 
of EU-26 countries. It is readily apparent that in Finland the role of ambient particles 
is lower than in Europe in general, but that both bio-aerosols (pollen) and radon play 
much more significant roles. Especially the contribution of radon is double to that of 
the European average, highlighting the geology peculiarities of the Finnish soil. 
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However, in Finland the burden of disease from lung cancer caused by radon 
exposures is alleviated partly by lower smoking prevalence. On average, 31% of over 
15-year olds smoke daily or occasionally in EU countries and the smoking figures are 
lower only in Finland (25%), Sweden (25%) and Slovakia (22%) [21]. 
Dampness and mould problems continuously raise a lot of attention in Finland, too. 
Nevertheless, the burden of disease in Finland is from the lower end on the European 
scale (ranging from 1% to 11%), and only 3% is estimated to be caused by dampness 
in comparison with average of 5% in EU-26. 
 
Figure 3. 
Control scenario benefits including optimal ventilation 
The burden of disease caused by indoor exposures, estimated above to be over 4 000 
DALYs per year per a population of 1 million in EU-26, is significant. However, also 
substantial reductions have been proposed in the earlier work within the EU funded 
IAIAQ project [20]. The three alternative scenarios (and two additional source control 
scenarios) described earlier were tested to support policy development for controlling 
the risks and reducing the burden. The overall comparison of these scenarios in EU-26 
is presented in Figure 4. The achievable health benefits were 20% for the dilution 
scenario, 38% for the filtration scenario, and 44% for the indoor source control 
scenario (changing from 41% to 54% depending on assumed source reductions). 
 
Figure 4. 
 
Each control scenario provides noteworthy health benefits. However, in the dilution-
based scenario 1 the health benefits remain smallest because the reduction of indoor 
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originating exposures is compensated by infiltration of outdoor pollution when 
increasing ventilation rates. The European health optimum (lowest burden of disease 
achieved by changing national ventilation level) is found at mean ventilation level of 
4.4 lps pp, which is clearly lower than the mean ventilation in the existing building 
stock (17 lps pp) defined by the regression modelled probability distributions (Table 
1) [16, 17]. 
Approximately twice as high benefits are achievable by filtration of outdoor air in 
scenario 2. The results for maximum feasible filtration (with penetration fraction P = 
50%) show that reduction in burden of disease approach 38 % or 800 000 DALYs in 
EU-26. The European optimum mean ventilation level is then 7.7 lps pp. Health-
optimized ventilation level in addition to the filtration produces small additional 
improvements. This scenario would in practice imply substantial change towards 
mechanical ventilation systems in Europe. In the Nordic countries this is already the 
practice due to the energy efficiency norms, but in the majority of the European 
building stock the filtration scenario would require a substantial step towards 
installing mechanical systems. 
However, largest health benefits can be achieved by the source control approach 
(scenario 3.0), which significantly reduces the need to control exposures by dilution. 
The benefits are approximately 44% from the baseline, or 940 000 DALYs in EU-26, 
and changing from reduction of 41% (865 000 DALY) with lower source control 
assumptions to 57% (1.21 million DALY) with higher source control assumptions, 
demonstrating source control to be more effective than dilution or filtration even with 
smaller reductions of source exposures.  
In addition to of higher health benefits, in comparison with the filtration-based 
scenario 2 the advantage is that with source control the lower dilution need (i.e. 
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enabling lower ventilation rate) allow also for lower infiltration of outdoor particles 
and therefore the feasibility of the approach is better in the current building stock. 
Moreover, with lower ventilation rates require the source control approach is likely to 
prove also more energy-efficient. 
Further analysis of the contribution of indoor and outdoor sources on these scenarios 
shows, that with the dilution scenario the health benefits are not only due to smaller 
proportion of the indoor contribution (i.e. the dilution of the pollutants from the 
indoor sources) but is mainly based on the lower ventilation rates that actually limits 
the penetration of the outdoor pollutants to indoors. 
In the filtration scenario the health benefits are due to filtration of the outdoor 
pollutants and also effective dilution of the indoor pollutants as the health-based 
optimal ventilation levels are higher.  
Also in the source control scenarios the health benefits are a result of both effects; 
firstly by the lower indoor sources due to the source control and secondly by lower 
penetration of outdoor pollutants due to low level of ventilation.  
Discussion  
The results suggest that (i) there is a substantial burden of disease associated with 
exposures through inhalation taking place indoors and that (ii) these risks can 
substantially be reduced by various policies that include a range of control actions 
affecting indoor pollution sources, infiltration of outdoor pollutants, and ventilation 
levels. Besides the estimated health benefits and policy implementation costs, the 
suggested prioritization of the policies depends also on the uncertainties of the 
estimates. 
Model uncertainties are causing the largest concerns here. They include the selection 
of pollutants and health end-points associated with them. It is clear that in the current 
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context a substantial uncertainty is raised from here: it is not clear how much the 
burden of disease estimates are underestimated due to the dozens of ignored 
exposures or missing health endpoints for the included exposures. At best the model 
uncertainties can and should be qualitatively judged by experts before the general 
implementation of results. 
Parameter uncertainties are easiest to estimate and evaluate. Quantification of the 
exposure-response relationships and mass-balance model for exposures belong also to 
the parameter uncertainties. Variable degree of uncertainty exists in the exposure-
response response relationships based on epidemiological studies. For some of the 
included pollutants, like PM2.5 originating from outdoor air, this data is based on a 
large number of studies, representing very large populations in different 
climatological regions. The exposure-response relationship of ambient particles has 
also been used for indoor generated particles. The indoor generated particles have 
partly similar composition, originating from combustion processes or being re-
suspended particles originating from soil, for which it is reasonable to assume similar 
toxicity as for the ambient particles. Some particle fractions, especially the particles 
from cooking of food, from the occupants, and from textiles, have a different 
chemical composition with limited direct evidence on their toxicity. 
Scenario uncertainties are inherent for any future forecasts; we may not know all 
changes in the systems under investigation and therefore must rely on assumptions. 
When selecting policies for implementation, the implementation timeframe should 
also be considered. Most significant element in the scenario uncertainties is related to 
the development of future building stocks. The current ventilation guidelines are 
intentionally formulated so that the focus is on the key parameters in terms of health, 
the exposures, and there are as little as possible elements that require specific 
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technical solutions. An example of such an issue is the filtration of outdoor air 
pollution, especially PM2.5, but also pollen, other biological particles, ozone, ultrafine 
traffic particles and so on. Infiltration of ambient particles depends on air exchange 
rates, size distribution of the outdoor particles, and filtration of the intake air. At 
lower air exchange rates the prolonged residence time of air indoors and 
corresponding deposition of particles on indoor surfaces reduces indoor exposures 
even when the outdoor air is not filtrated. Using window frames and other 
sedimentation chambers allows for filtrating particles even in natural ventilation 
systems. Nevertheless, active filtration becomes efficient only in mechanical systems 
using high quality (above FP7) filters. 
The used ventilation rate estimates per occupant (lps pp) are calculated using average 
residence sizes and average numbers of occupants in each country. Population 
weighted average outdoor concentrations have also been used in estimating the indoor 
exposures. It is clear that the air filtration needs for a specific building have to be 
defined using the ambient air quality at the selected building location. In all countries 
considered there are locations where the outdoor levels exceed the WHO guidelines 
much more than the national averages used here indicate. When the current methods 
proposed for determining the potential filtration needs, they have to be applied with 
worst case estimates for the actual building site, accounting for the whole service life 
cycle. 
Largest health benefits were projected for the source control policies. It is obvious 
that the benefits are achievable only if the source controls work as efficiently as 
proposed and that the efficiency of the source controls must be confirmed with 
follow-up (e.g. auditing) of exposure levels after the policy enforcement. 
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Conclusions  
Over 2 million disability adjusted life years (DALY) are annually lost in the European 
Union due to compromised indoor air quality, but this burden of disease can be 
reduced by adjusting ventilation, filtration of intake air and by controlling indoor 
sources. All three approaches are able to provide substantial reductions in the health 
risks from approximately 20 % to almost 50%, corresponding to 400 000 and 900 000 
saved DALYs in EU-26. Thus selection of strategies has substantial impact on the 
expected benefits. 
The projected health benefits can be achieved if the controls on ventilation and 
sources are fully implemented as defined in the scenario descriptions. In the case of 
selecting some of the proposed strategies for implementation, a careful follow-up plan 
has to be developed for ensuring that the controls are effective and match the 
requirements of the benefit calculations. 
List of abbreviations used 
BoD = burden of disease  
CO = carbon monoxide  
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PAF = population attributable fraction 
PAQ = perceived air quality 
PM2.5 = particulate matter sized < 2.5 mm  
RR = relative risk 
SARS = severe acute respiratory syndrome  
SBS = sick building syndrome 
SHS = second hand smoke 
VOC = volatile organic compounds 
WHO = World Health Organization 
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Figure legends 
 
Figure 1. Attributable burden of diseases due to indoor exposures in 2010 in 
EU-26. The lighter shade represents the maximum fraction that can be reduced 
by actions (scenarios) presented in this paper  
 
Figure 2. Total burden of disease as DALY/million population from indoor 
exposures in EU-26 countries with division to indoor and outdoor sources in 
the 2010 building stock 
 
Figure 3. Burden of disease attributable to indoor exposures in EU-26 (2.1 M 
DALY/a) and in Finland (13 k DALY/a) in 2010 divided into source contributions. 
 
Figure 4. Burden of disease at the baseline (2010) in comparison with 
alternative potential control strategies in EU-26 (in millions of DALYs). 
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Tables 
Table 1. Estimated ventilation rate distributions in European countries [17]. 
 
Air exchange rate Ventilation rate per occupant 
Country Mean Median 
One-GSD 
Mean Median 
One-GSD 
range
a
 range
a
 
  h
-1
 h
-1
 h
-1
 lps pp lps pp lps pp 
Austria 0,9 0,7 (0.4-1.3) 25 21 (11.1-39.1) 
Belgium 0,7 0,6 (0.3-1.1) 17 14 (7.6-26.7) 
Bulgaria 0,7 0,6 (0.3-1.1) 15 12 (6.4-22.3) 
Cyprus 1,2 1,0 (0.5-1.9) 24 20 (10.6-37.2) 
Czech Republic 0,6 0,5 (0.3-1.0) 14 11 (6.0-21.1) 
Denmark 0,7 0,5 (0.3-1.0) 24 20 (10.4-36.6) 
Estonia 0,7 0,5 (0.3-1.0) 13 10 (5.5-19.4) 
Finland 0,7 0,5 (0.3-1.0) 17 14 (7.5-26.3) 
France 0,6 0,5 (0.3-1.0) 18 14 (7.7-27.1) 
Germany 0,7 0,6 (0.3-1.0) 20 17 (8.8-31.0) 
Greece 1,0 0,8 (0.4-1.5) 20 17 (8.8-30.9) 
Hungary 0,8 0,6 (0.3-1.2) 16 13 (6.8-24.0) 
Ireland 0,6 0,5 (0.3-0.9) 14 12 (6.2-21.9) 
Italy 0,8 0,6 (0.3-1.2) 21 17 (9.2-32.4) 
Latvia 0,7 0,5 (0.3-1.0) 11 9 (4.9-17.2) 
Lithuania 0,7 0,6 (0.3-1.0) 11 9 (4.9-17.3) 
Luxembourg 0,9 0,7 (0.4-1.3) 32 26 (14.1-49.5) 
Netherlands 0,7 0,6 (0.3-1.0) 21 17 (9.1-32.1) 
Poland 0,7 0,6 (0.3-1.1) 11 9 (4.8-16.7) 
Portugal 0,7 0,6 (0.3-1.1) 15 12 (6.6-23.1) 
Romania 0,8 0,6 (0.3-1.2) 7 6 (3.2-11.1) 
Slovakia 0,8 0,6 (0.3-1.2) 12 10 (5.1-17.9) 
Slovenia 0,7 0,6 (0.3-1.1) 13 11 (5.9-20.7) 
Spain 0,8 0,7 (0.3-1.2) 20 17 (8.9-31.3) 
Sweden 0,6 0,5 (0.3-1.0) 20 17 (9.0-31.5) 
UK 0,6 0,5 (0.3-0.9) 15 13 (6.8-23.8) 
EU-26 0,7 0,6 (0.3-1.1) 17 14 (7.3-25.6) 
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Table 2. Outdoor and indoor exposure levels (PM2.5, radon and VOC) and 
prevalence of exposure (dampness in homes and second hand smoke of non-
smoking population) in European countries used for burden of disease 
calculations. 
 
 
Out. 
PM2.5 
Ind. 
PM2.5 
Out. 
VOC 
Ind. 
VOC 
Ind. 
Radon 
Dampness 
homes  
SHS non-
smokers 
  µg m-3 µg m-3 µg m-3 µg m-3 Bq m-3 % % 
Austria 17 5 103 298 97 8 14 
Belgium 19 5 103 298 69 14 18 
Bulgaria 22 5 103 298 30 n/a 23 
Cyprus 23 4 103 298 7 30 31 
Czech Republic 23 5 116 334 140 16 16 
Denmark 13 3 103 298 53 11 17 
Estonia 11 3 103 298 120 23 16 
Finland 9 3 64 226 120 5 2 
France 12 5 77 223 89 14 9 
Germany 16 5 103 297 50 13 13 
Greece 21 4 155 345 55 19 28 
Hungary 25 5 103 298 107 19 12 
Ireland 8 3 103 298 89 15 14 
Italy 20 4 181 489 70 21 11 
Latvia 12 3 103 298 0 26 12 
Lithuania 14 3 103 298 55 25 28 
Luxembourg 12 5 52 148 115 15 8 
Netherlands 19 5 46 134 30 18 15 
Poland 22 5 103 298 49 37 21 
Portugal 18 4 38 213 86 20 13 
Romania 23 5 103 298 45 29 23 
Slovakia 23 5 103 298 87 6 13 
Slovenia 17 5 103 298 87 17 14 
Spain 16 4 103 298 90 18 20 
Sweden 10 3 77 223 108 6 3 
UK 13 3 85 245 20 15 7 
EU-26 17 4 104 297 64 18 14 
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Table 3. Diseases and exposure-response relationships included in this 
assessment. 
Exposures
a 
Health endpoints WHO RR PAF RR & PAF 
source(s) 
BoD calculation
b
  
PM2.5  Asthma W113 –
c
 f(RR, E)
d
 Pope et al. 2002  PAF(E, RR) × BoD2004 
 Lung cancer W067 –
c
 f(RR, E)
d
 Pope et al. 2002 PAF(E, RR) × BoD2004 
 CV-diseases W104 –
c
 f(RR, E)
d
 Pope et al. 2002 PAF(E, RR) × BoD2004 
 COPD W112 –
c
 f(RR, E)
d
 Pope et al. 2002 PAF(E, RR) × BoD2004 
Outdoor 
bioaerosols 
Asthma W113 –
c
 0.1
e
 Jantunen et al., 
2010 [20] 
PAF × BoD2004 
VOC Asthma W113 –
c
 0.05 Jantunen et al., 
2010 [20] 
C/CEU × PAF × BoD2004 
CO Acute toxication caused 
by carbon monoxide 
n/a –
c
 0.9 Jantunen et al., 
2010 [20] 
Cases x 20 years 
lost/case 
Radon Lung cancer W067 0.0014 f(RR, E)
d
 Darby et al., 2005 
[ 
PAF(E, RR) × BoD2004 
Home dampness Respiratory infections W038 1.37 f(RR, E)
d
 Fisk et al., 2007 PAF(E, RR) × BoD2004 
 Asthma W113 1.5 f(RR, E)
d
 Fisk et al., 2007 PAF(E, RR) × BoD2004 
SHS
f
 Lung cancer W067 1.21 f(RR, E)
d
 US S.G. 2006 PAF(E, RR) × BoD2004 
 Ischaemic heart 
disease 
W107 1.27 f(RR, E)
d
 US S.G. 2006 PAF(E, RR) × BoD2004 
 Asthma W113 1.97 f(RR, E)
d
 Jaakkola et al., 
2003 
PAF(E, RR) × BoD2004 
a
 Population weighted average in EU26 
b
 C = National population weighted concentration, CEU = European average 
concentration, E = National population weighted exposure 
c
 Expert judgment PAF from the EnVIE panel used directly [19], see column PAF 
d
 Calculated as PAF=(f×(RR-1))/((f×(RR-1))+1), where RR = RR°E [Error! 
Reference source not found.]. 
e
 Original value of 0.25 in Jantunen et al. (2010) [20] adjusted to 0.1 due to separation 
of indoor and outdoor sources and focusing on pollen from outdoor air 
f
 Second hand smoke exposure of non-smoking adults at home.  
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Table 4. Contribution (%) of different sources to the total DALYs in 2010. 
  
Ind. 
PM2.5 Radon 
Ind. 
VOC CO Damp. SHS 
Out. 
PM2.5 
Bio-
aeros
ols 
Out. 
VOC 
Austria 18 11 1 1 1 5 58 3 0 
Belgium 18 9 1 0 4 4 60 3 0 
Bulgaria 17 2 0 0 3 2 74 1 0 
Cyprus 11 0 1 0 11 12 61 3 0 
Czech Republic 14 12 1 4 3 3 61 2 0 
Denmark 13 9 2 3 3 6 59 5 1 
Estonia 14 13 1 5 8 4 52 3 0 
Finland 16 16 2 4 3 2 50 7 1 
France 20 18 2 0 5 2 46 6 1 
Germany 20 6 1 1 3 4 60 3 0 
Greece 14 6 1 1 4 5 68 2 0 
Hungary 15 12 0 1 1 1 69 1 0 
Ireland 13 12 4 2 11 12 34 11 1 
Italy 14 9 2 1 4 3 64 3 1 
Latvia 15 6 1 2 7 3 64 2 0 
Lithuania 14 5 0 0 6 10 63 1 0 
Luxembourg 21 15 1 1 6 3 47 5 0 
Netherlands 18 4 1 1 6 5 61 5 0 
Poland 15 5 1 1 6 3 66 2 0 
Portugal 14 7 1 1 7 4 62 4 0 
Romania 16 3 0 1 7 2 70 1 0 
Slovakia 16 7 1 1 2 3 70 2 0 
Slovenia 17 11 1 2 5 3 56 3 0 
Spain 14 14 1 0 5 4 57 4 0 
Sweden 16 15 2 2 3 3 54 6 1 
United 13 3 2 1 8 5 59 8 1 
EU-26 16 8 1 1 5 4 62 3 0 
 
